Tag: female viagra

Flibanserin’s ‘Effects’ Do Not Outweigh Harms, Review Finds

7
Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...

‚ÄúStudy Shows Addyi is Not ‚ÄėFemale Viagra‚Äô by Any Stretch of...

1
Pharmaguy covers a study published in JAMA this month which found that Addyi, the new drug approved by the FDA to treat low sexual...

‚ÄúWas Sexism Really Responsible for the FDA’s Hesitancy to Sign Off...

0
‚ÄúThe Food and Drug Administration‚Äôs approval of pharmaceutical treatment for low sexual desire in women has launched a heated debate over the dangers and benefits of medicalizing sex,‚ÄĚ Maya Dusenbery writes in the Pacific Standard. Is ‚Äúfemale Viagra‚ÄĚ a feminist victory or a product of clever faux-feminist marketing by Big Pharma?

‚ÄúControversial ‚ÄėFemale Viagra‚Äô Hits the Market, New Questions Arise‚ÄĚ

1
Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women

Members of FDA Advisory Committee Offer Perspectives on Flibanserin Approval in...

5
In the September issue of The Journal of the American Medical Association (JAMA) three FDA advisory committee members describe the convergence of factors that made the committee’s recommendation to approve flibanserin especially challenging and politically charged.

‚ÄúFlibanserin, ‘Female Viagra,’ Distracts From Real Causes of Low Libido‚ÄĚ

4
CBC News Canada voices sex therapists and psychiatrists concerns over the FDAs decision to approve Flibanserin last week. Critics contend, ‚Äúit's an ineffectual pharmacological solution for a problem better treated with relationship counselling, sex therapy and behavioural changes.‚ÄĚ Walid Gellad, the co-director of the Center for Pharmaceutical Policy and Prescribing adds, ‚Äú"[I] believe that it should be used by almost no one.‚ÄĚ